Cargando…

Sensitivity to inhibition of DNA repair by Olaparib in novel oropharyngeal cancer cell lines infected with Human Papillomavirus

The incidence of Human Papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma (OPSCC) is increasing rapidly in the UK. Patients with HPV-positive OPSCC generally show superior clinical responses relative to HPV-negative patients. We hypothesised that these superior responses could be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pirotte, Evelyne F., Holzhauser, Stefan, Owens, David, Quine, Stuart, Al-Hussaini, Ali, Christian, Adam D., Giles, Peter J., Man, Stephen T., Evans, Mererid, Powell, Ned G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292594/ https://www.ncbi.nlm.nih.gov/pubmed/30543656 http://dx.doi.org/10.1371/journal.pone.0207934

Ejemplares similares

Human Papillomavirus-associated oropharyngeal cancer: an observational study of diagnosis, prevalence and prognosis in a UK population
por: Evans, Mererid, et al.
Publicado: (2013)

PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer
por: Owadally, Waheeda, et al.
Publicado: (2015)

Deintensification of Adjuvant Treatment After Transoral Surgery in Patients With Human Papillomavirus-Positive Oropharyngeal Cancer: The Conception of the PATHOS Study and Its Development
por: Hargreaves, Sarah, et al.
Publicado: (2019)

Modelling human papillomavirus biology in oropharyngeal keratinocytes
por: Roberts, Sally, et al.
Publicado: (2019)

Oropharyngeal Cancer Epidemic and Human Papillomavirus
por: Ramqvist, Torbjörn, et al.
Publicado: (2010)

High Levels of FGF11 Correlate with Poor Survival in Patients with Human Papillomavirus (HPV)-Positive Oropharyngeal Squamous Cell Carcinoma
por: de Flon, Caroline Haglund, et al.
Publicado: (2023)

Geographic variation in human papillomavirus–related oropharyngeal cancer: Data from 4 multinational randomized trials
por: Mehanna, Hisham, et al.
Publicado: (2016)

JF-305, a pancreatic cancer cell line is highly sensitive to the PARP inhibitor olaparib
por: YANG, XUELI, et al.
Publicado: (2015)

Metformin Affects Olaparib Sensitivity through Induction of Apoptosis in Epithelial Ovarian Cancer Cell Lines
por: Gralewska, Patrycja, et al.
Publicado: (2021)

PARP inhibitor olaparib sensitizes cholangiocarcinoma cells to radiation
por: Mao, Yize, et al.
Publicado: (2018)

Human papillomavirus and oropharyngeal cancer in Greenland in 1994–2010
por: Avnstorp, Magnus Balslev, et al.
Publicado: (2013)

Defective DNA repair mechanisms in prostate cancer: impact of olaparib
por: De Felice, Francesca, et al.
Publicado: (2017)

Ceralasertib-Mediated ATR Inhibition Combined With Olaparib in Advanced Cancers Harboring DNA Damage Response and Repair Alterations (Olaparib Combinations)
por: Mahdi, Haider, et al.
Publicado: (2021)

Olaparib modulates DNA repair efficiency, sensitizes cervical cancer cells to cisplatin and exhibits anti-metastatic property
por: Prasad, Chandra Bhushan, et al.
Publicado: (2017)

The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin
por: Ordóñez, José Luis, et al.
Publicado: (2015)

Zebrafish Xenografts Unveil Sensitivity to Olaparib beyond BRCA Status
por: Varanda, Ana Beatriz, et al.
Publicado: (2020)

Efficiency of olaparib in colorectal cancer patients with an alteration of the homologous repair protein
por: Ghiringhelli, Francois, et al.
Publicado: (2016)

Recent advances in managing human papillomavirus-positive oropharyngeal tumors
por: Cantu, Giulio, et al.
Publicado: (2010)

Ultrasensitive detection of oncogenic human papillomavirus in oropharyngeal tissue swabs
por: Isaac, Andre, et al.
Publicado: (2017)

Public awareness of the association between human papillomavirus and oropharyngeal cancer
por: Verhees, Femke, et al.
Publicado: (2021)

Human Papillomavirus Detected in Oropharyngeal Cancers from Chilean Subjects
por: Oliva, Carolina, et al.
Publicado: (2022)

Human papillomavirus-mediated carcinogenesis and HPV-associated oral and oropharyngeal squamous cell carcinoma. Part 2: Human papillomavirus associated oral and oropharyngeal squamous cell carcinoma
por: Feller, Liviu, et al.
Publicado: (2010)

ATM-Deficient Colorectal Cancer Cells Are Sensitive to the PARP Inhibitor Olaparib()
por: Wang, Chen, et al.
Publicado: (2017)

Rapamycin sensitizes cancer cells to growth inhibition by the PARP inhibitor olaparib
por: Osoegawa, Atsushi, et al.
Publicado: (2017)

Correction: The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin
por: Ordóñez, José Luis, et al.
Publicado: (2017)

Olaparib as maintenance treatment for patients with platinum-sensitive relapsed ovarian cancer
por: Ledermann, Jonathan A., et al.
Publicado: (2019)

PARP inhibitor Olaparib increases the sensitization to radiotherapy in FaDu cells
por: Liu, Chuan, et al.
Publicado: (2020)

Systematic Review of Olaparib in the Treatment of Recurrent Platinum Sensitive Ovarian Cancer
por: Chen, Qian, et al.
Publicado: (2022)

Evidence of the causal role of human papillomavirus type 58 in an oropharyngeal carcinoma
por: Baboci, Lorena, et al.
Publicado: (2013)

The prevalence of human papillomavirus in oropharyngeal cancer in a New Zealand population
por: Lucas-Roxburgh, Rebecca, et al.
Publicado: (2017)

De-intensification of adjuvant therapy in human papillomavirus-associated oropharyngeal cancer
por: An, Yi, et al.
Publicado: (2016)

Educational Case: Human Papillomavirus–Positive Oropharyngeal Squamous Cell Carcinoma
por: Shen, Minqian, et al.
Publicado: (2019)

An economic and disease transmission model of human papillomavirus and oropharyngeal cancer in Texas
por: Zhong, Chengxue, et al.
Publicado: (2021)

Diverse tumorigenic consequences of human papillomavirus integration in primary oropharyngeal cancers
por: Symer, David E., et al.
Publicado: (2022)

Pretreatment prognostic factor for patients with human papillomavirus related oropharyngeal cancer
por: Sano, Daisuke, et al.
Publicado: (2019)

Pathogenic Role of Immune Evasion and Integration of Human Papillomavirus in Oropharyngeal Cancer
por: Hatano, Takashi, et al.
Publicado: (2021)

Human Papillomavirus Infection and Oropharyngeal and Gastrointestinal Cancers: A Causal Relationship?
por: Deniz, Zeynep, et al.
Publicado: (2022)

Prevalence and Characteristics of Human Papillomavirus Infection in Oropharyngeal Squamous Cell Papilloma
por: Ahn, Dongbin, et al.
Publicado: (2023)

The relation between human papillomavirus (HPV) and oropharyngeal cancer: a review
por: Ferreira, Chrystiano Campos
Publicado: (2023)

Uneven Expression of 20 Human Papillomavirus Genes Associated with Oropharyngeal Carcinoma
por: Dawood, Ali Adel
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qd2je5d47t0ml37fhv2cvjpoe4